• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Gland Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
543245
INE068V01023
655.111941
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAND
33.57
47417.52
EPS(TTM)
Face Value()
Div & Yield %
85.6
1
0.7
 

Board of Jaykay Enterprises approves acquisition of business undertaking of Patange Industries
Apr 13,2026
The board of Jaykay Enterprises at its meeting held today, i.e. 13 April 2026, has considered and approved the acquisition of the Business Undertaking of Patange Industries (PIPL), engaged in the business of defence precision manufacturing, fabrication and engineering design services, by way of a slump sale on a going concern basis.

The acquisition strengthens the company's strategic objective to expand its presence in the defence and aerospace sector.